One-carbon metabolism and bipolar disorder

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 11, 2013, Pages 1013-1018

  Baek, Ji Hyun ^a   Bernstein, Emily E ^a   Nierenberg, Andrew A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorder; folate; mood disorder; nutraceuticals

Indexed keywords

5 METHYLFOLATE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIDEPRESSANT AGENT; CARBON; FLUOXETINE; FOLIC ACID; FOLINIC ACID; HOMOCYSTEINE; LAMOTRIGINE; METHOTREXATE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; UNCLASSIFIED DRUG; VALPROIC ACID;

ADJUVANT THERAPY; BIPOLAR DISORDER; BIPOLAR MANIA; CARBON METABOLISM; DEPRESSION; DRUG EFFECT; EPILEPSY; FOLATE METABOLISM; GENETIC VARIABILITY; GENETICS; HUMAN; MAJOR DEPRESSION; METHYLATION; MONOAMINE METABOLISM; MOOD DISORDER; REVIEW; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

BIPOLAR DISORDER; FOLATE; MOOD DISORDER; NUTRACEUTICALS;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; FOLIC ACID; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); TRIAZINES; VALPROIC ACID;

EID: 84887447032     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413502091     Document Type: Review

References (68)

1. Abdolmaleky HM, Smith CL, Faraone SV, et al. Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. Am American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics. 2004 ; 127B: 51-59
2. Abou-Saleh MT, Coppen A. The efficacy of low-dose lithium: Clinical, psychological and biological correlates. Journal of Psychiatric Research. 1989 ; 23: 157-162
3. Akoglu B, Schrott M, Bolouri H, et al. The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study. European Journal of Clinical Nutrition. 2008 ; 62: 796-801
4. Almeida OP, Flicker L, Lautenschlager NT, et al. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life. Neurobiology of Aging. 2005 ; 26: 251-257
5. Alpert JE, Mischoulon D, Rubenstein GE, et al. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists. 2002 ; 14: 33-38
6. Altshuler LL, Gitlin MJ, Mintz J, et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. Journal of Clinical Psychiatry. 2002 ; 63: 807-811
7. Arinami T, Yamada N, Yamakawa-Kobayashi K, et al. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. American Journal of Medical Genetics. 1997 ; 74: 526-528
8. Behzadi AH, Omrani Z, Chalian M, et al. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: A double-blind randomized controlled trial. Acta Psychiatrica Scandinavica. 2009 ; 120: 441-445
9. Belcastro V, Striano P, Gorgone G, et al. Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia. 2010 ; 51: 274-279
10. Bjelland I, Tell GS, Vollset SE, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Archives of General Psychiatry. 2003 ; 60: 618-626
11. Bochyńska A, Lipczyńska-Łojkowska W, Gugała-Iwaniuk M, et al. The effect of vitamin B supplementation on homocysteine metabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid. Seizure: The Journal of the British Epilepsy Association. 2012 ; 21: 276-281
12. Botez M, Botez T, Leveille J, et al Folic Acid in Neurology, Psychiatry, and Internal Medicine. Botez MI Reynolds EH, ed. New York: Raven Press ; 1979: 435.
13. Bottiglieri T, Hyland K, Laundy M, et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychological Medicine. 1992 ; 22: 871-876
14. Bottiglieri T, Laundy M, Crellin R, et al. Homocysteine, folate, methylation, and monoamine metabolism in depression. Journal of Neurology, Neurosurgery, and Psychiatry. 2000 ; 69: 228-232
15. Carney MW. Serum folate values in 423 psychiatric patients. British Medical Journal. 1967 ; 4: 512-516
16. Carney MW, Chary TK, Laundy M, et al. Red cell folate concentrations in psychiatric patients. Journal of Affective Disorders. 1990 ; 19: 207-213
17. Cohen-Woods S, Craig I, Gaysina D, et al. The Bipolar Association Case-Control Study (BACCS) and meta-analysis: No association with the 5,10-Methylenetetrahydrofolate reductase gene and bipolar disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics. 2010 ; 153B: 1298-1304
18. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial. Journal of Affective Disorders. 2000 ; 60: 121-130
19. Coppen A, Bolander-Gouaille C. Treatment of depression: Time to consider folic acid and vitamin B12. Journal of Psychopharmacology/British Association for Psychopharmacology. 2005 ; 19: 59-65
20. Coppen A, Chaudhry S, Swade C. Folic acid enhances lithium prophylaxis. Journal of Affective Disorders. 1986 ; 10: 9-13
21. Crellin R, Bottiglieri T, Reynolds EH. Folates and psychiatric disorders. Clinical potential. Drugs. 1993 ; 45: 623-636
22. Di Palma C, Urani R, Agricola R, et al. Is methylfolate effective in relieving major depression in chronic alcoholics? A hypothesis of treatment. Current Therapeutic Research. 1994 ; 55: 559-568
23. Edeh J, Toone BK. Antiepileptic therapy, folate deficiency, and psychiatric morbidity: a general practice survey. Epilepsia. 1985 ; 26: 434-440
24. Ezzaher A, Mouhamed DH, Mechri A, et al. Hyperhomocysteinemia in Tunisian bipolar I patients. Psychiatry and Clinical Neurosciences. 2011 ;: 664-671
25. Folstein M, Liu T, Peter I, et al. The homocysteine hypothesis of depression. American Journal of Psychiatry. 2007 ; 164: 861-867
26. Gaysina D, Cohen S, Craddock N, et al. No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: Results of the depression case control (DeCC) study and a meta-analysis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics. 2008 ; 147B: 699-706
27. Ghadirian AM, Ananth J, Engelsmann F. Folic acid deficiency and depression. Psychosomatics. 1980 ; 21: 926-929
28. Gidal BE, Tamura T, Hammer A, et al. Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy. Epilepsy Research. 2005 ; 64: 161-166
29. Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. American Journal of Epidemiology. 2007 ; 165: 1-13
30. Glaxo SmithKline (2011) Lamictal medication guide. Available at: http://us.gsk.com/products/assets/us-lamictal.pdf (accessed 5 August 2013).
31. Godfrey PS, Toone BK, Carney MW, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 1990 ; 336: 392-395
32. Görtz P, Hoinkes A, Fleischer W, et al. Implications for hyperhomocysteinemia: Not homocysteine but its oxidized forms strongly inhibit neuronal network activity. Journal of the Neurological Sciences. 2004 ; 218: 109-114
33. Guaraldi GP, Fava M, Mazzi F, et al. An open trial of methyltetrahydrofolate in elderly depressed patients. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists. 1993 ; 5: 101-105
34. Herbert V. The assay and nature of folic acid activity in human serum. Journal of Clinical Investigation. 1961 ; 40: 81-91
35. Hill M, Shannahan K, Jasinski S, et al. Folate supplementation in schizophrenia: A possible role for MTHFR genotype. Schizophrenia Research. 2011 ; 127: 41-45
36. Joffe RT, MacQueen GM, Marriott M, et al. A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders. Bipolar Disorders. 2004 ; 6: 62-66
37. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry. 2002 ; 59: 530-537
38. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry. 2003 ; 60: 261-269
39. Karabiber H, Sonmezgoz E, Ozerol E, et al. Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain & Development. 2003 ; 25: 113-115
40. Kelly CB, McDonnell AP, Johnston TG, et al. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. Journal of Psychopharmacology/British Association for Psychopharmacology. 2004 ; 18: 567-571
41. Kruman II, Culmsee C, Chan SL, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2000 ; 20: 6920-6926
42. Linnebank M, Moskau S, Semmler A, et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Annals of Neurol. 2011 ; 69: 352-359
43. Mischoulon D, Alpert JE, Arning E, et al. Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder. Journal of Clinical Psychiatry. 2012a ; 73: 843-848
44. Mischoulon D, Lamon-Fava S, Selhub J, et al. Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. CNS Spectrums. 2012b ; 17: 76-86
45. Osher Y, Bersudsky Y, Silver H, et al. Neuropsychological correlates of homocysteine levels in euthymic bipolar patients. Journal of Affective Disorders. 2008 ; 105: 229-233
46. Papakostas GI, Petersen T, Mischoulon D, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: Predictors of clinical response in fluoxetine-resistant depression. Journal of Clinical Psychiatry. 2004a ; 65: 1090-1095
47. Papakostas GI, Petersen T, Mischoulon D, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: Predictors of relapse during the continuation phase of pharmacotherapy. Journal of Clinical Psychiatry. 2004b ; 65: 1096-1098
48. Papakostas GI, Shelton RC, Zajecka JM, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: Results of two randomized, double-blind, parallel-sequential trials. American Journal of Psychiatry. 2012 ; 169: 1267-1274
49. Passeri M, Cucinotta D, Abate G, et al. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: Results of a double-blind multicenter study. Aging: Clinical and Experimental Research. 1993 ; 5: 63-71
50. Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). American Journal of Psychiatry. 2006 ; 163: 217-224
51. Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. Journal of Clinical Psychiatry. 2003 ; 64: 680-690
52. Reif A, Pfuhlmann B, Lesch KP. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2005 ; 29: 1162-1168
53. Resler G, Lavie R, Campos J, et al. Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes. Neuroimmunomodulation. 2008 ; 15: 145-152
54. Reynolds EH Advances in Epileptology: the XIIth Epilepsy International Symposium. Dam M Gram L Penry JK, ed. New York: Raven Press ; 1981: 621.
55. Reynolds EH, Preece JM, Bailey J, et al. Folate deficiency in depressive illness. British Journal of Psychiatry: The Journal of Mental Science. 1970 ; 117: 287-292
56. Scott JM, Weir DG. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet. 1981 ; 2: 337-340
57. Shorvon SD, Carney MW, Chanarin I, et al. The neuropsychiatry of megaloblastic anaemia. British Medical Journal. 1980 ; 281: 1036-1038
58. Stahl SM. Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectrums. 2007 ; 12: 739-744
59. Tamura T, Aiso K, Johnston KE, et al. Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy. Epilepsy Research. 2000 ; 40: 7-15
60. Taylor MJ, Carney SM, Geddes J, et al. Folate for depressive disorders. Cochrane Database of Systematic Reviews. 2003 ; 2 :
61. Tolmunen T, Voutilainen S, Hintikka J, et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. Journal of Nutrition. 2003 ; 133: 3233-3236
62. Tremolizzo L, Carboni G, Ruzicka WB, et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proceedings of the National Academy of Sciences of the United States of America. 2002 ; 99: 17095-17100
63. Ubeda N, Alonso-Aperte E, Varela-Moreiras G. Acute valproate administration impairs methionine metabolism in rats. Journal of Nutrition. 2002 ; 132: 2737-2742
64. Verrotti A, Pascarella R, Trotta D, et al. Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Research. 2000 ; 41: 253-257
65. Wesson VA, Levitt AJ, Joffe RT. Change in folate status with antidepressant treatment. Psychiatry Research. 1994 ; 53: 313-322
66. Willems FF, Boers GH, Blom HJ, et al. Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease. British Journal of Pharmacology. 2004 ; 141: 825-830
67. Wilkinson AM, Anderson DN, Abou-Saleh MT, et al. 5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT. Journal of Affective Disorders. 1994 ; 32: 163-168
68. Zintzaras E, Ziogas DC, Kitsios GD, et al. MTHFR gene polymorphisms and response to chemotherapy in colorectal cancer: A meta-analysis. Pharmacogenomics. 2009 ; 10: 1285-1294